Skip to main content
Erschienen in: Journal of Cancer Survivorship 5/2023

05.01.2022

Importance of primary care for underserved cancer patients with multiple chronic conditions

verfasst von: Katelyn K. Jetelina, Simon Craddock Lee, Quiera S. Booker-Nubie, Udoka C. Obinwa, Hong Zhu, Michael E. Miller, Navid Sadeghi, Umber Dickerson, Bijal A. Balasubramanian

Erschienen in: Journal of Cancer Survivorship | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To understand the impact of pre-existing conditions on healthcare utilization among under- and uninsured patients in the transition from cancer treatment to post-treatment survivorship.

Methods

Using electronic health record data, we constructed a cohort of patients seen in an integrated county health system between 1/1/2010 and 12/31/2016. Six hundred thirty-one adult patients diagnosed with non-metastatic breast or colorectal cancer during this period (cases) were matched 1:1 on sex and Charlson comorbidity index to non-cancer patients who had at least two chronic conditions and with at least one visit to the health system during the study period (controls). Conditional fixed effects Poisson regression models compared number of primary care and emergency department (ED) visits and completed [vs. no show or missed] appointments between cancer and non-cancer patients.

Results

Cancer patients had significantly lower number of visits compared with non-cancer patients (N = 46,965 vs. 85,038). Cancer patients were less likely to have primary care (IRR = 0.25; 95% CI: 0.24, 0.27) and ED visits (IRR = 0.57; 95% CI: 0.50, 0.64) but more likely to complete a scheduled appointment (AOR = 4.83; 95% CI: 4.32, 5.39) compared with non-cancer patients. Cancer patients seen in primary care at a higher rate were more likely to visit the ED (IRR = 2.06; 95% CI: 1.52, 2.80) than those seen in primary care at a lower rate.

Conclusion

Health systems need to find innovative, effective solutions to increase primary care utilization among cancer patients with chronic care conditions to ensure optimal management of both chronic conditions and cancer.

Implications for Cancer Survivors

Maintaining regular connections with primary care providers during active cancer treatment should be promoted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cho H, et al. Assessing non-cancer-related health status of us cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol. 2013;178(3):339–49.CrossRefPubMedPubMedCentral Cho H, et al. Assessing non-cancer-related health status of us cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol. 2013;178(3):339–49.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Miller KD, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed Miller KD, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.CrossRefPubMed
4.
Zurück zum Zitat Hoopes M, et al. Identifying and characterizing cancer survivors in the US primary care safety net. Cancer. 2019;125(19):3448–56.CrossRefPubMed Hoopes M, et al. Identifying and characterizing cancer survivors in the US primary care safety net. Cancer. 2019;125(19):3448–56.CrossRefPubMed
5.
Zurück zum Zitat Williams MS et al. The association between hypertension and race/ethnicity among breast cancer survivors. J Racial Ethn Health Disparities. 2020;7(6):1172–1177 Williams MS et al. The association between hypertension and race/ethnicity among breast cancer survivors. J Racial Ethn Health Disparities. 2020;7(6):1172–1177
6.
Zurück zum Zitat Tammemagi CM, et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed Tammemagi CM, et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed
7.
Zurück zum Zitat Villarreal-Garza C, et al. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp Diabetes Res. 2012;2012:732027.CrossRefPubMedPubMedCentral Villarreal-Garza C, et al. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp Diabetes Res. 2012;2012:732027.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.CrossRefPubMed Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337–50.CrossRefPubMed
9.
Zurück zum Zitat SpringerLink (Online service) and Patricia A. Ganz. Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing : Imprint: Springer, 2015. SpringerLink (Online service) and Patricia A. Ganz. Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities. Cham: Springer International Publishing : Imprint: Springer, 2015.
10.
Zurück zum Zitat Hong C-C, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. In: Improving Outcomes for Breast Cancer Survivors. Springer; 2015. p. 155–75.CrossRef Hong C-C, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. In: Improving Outcomes for Breast Cancer Survivors. Springer; 2015. p. 155–75.CrossRef
11.
Zurück zum Zitat Pettit S, et al. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0176941.CrossRefPubMedPubMedCentral Pettit S, et al. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0176941.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yuan C, et al. Preexisting type 2 diabetes and survival among patients with colorectal cancer. Cancer Epidemiol Biomark Prev. 2021;30(4):757.CrossRef Yuan C, et al. Preexisting type 2 diabetes and survival among patients with colorectal cancer. Cancer Epidemiol Biomark Prev. 2021;30(4):757.CrossRef
13.
Zurück zum Zitat Starfield B. Primary care: Concept, evaluation, and policy. New York: Oxford University Press; 1992. Starfield B. Primary care: Concept, evaluation, and policy. New York: Oxford University Press; 1992.
14.
Zurück zum Zitat National Academies of Sciences, Engineering, and Medicine. 2021. Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. Washington, DC: The National Academies Press. https://doi.org/10.17226/25983. National Academies of Sciences, Engineering, and Medicine. 2021. Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. Washington, DC: The National Academies Press. https://​doi.​org/​10.​17226/​25983.
15.
Zurück zum Zitat Lafata JE, et al. Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015;9(2):201–7.CrossRefPubMed Lafata JE, et al. Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015;9(2):201–7.CrossRefPubMed
16.
Zurück zum Zitat Martin JY, et al. Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare. Cancer Med. 2017;6(9):2153–63.CrossRefPubMedPubMedCentral Martin JY, et al. Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare. Cancer Med. 2017;6(9):2153–63.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wallner LP, et al. Ten-year trends in preventive service use before and after prostate cancer diagnosis: a comparison with noncancer controls. Perm J. 2017;21:16–184.CrossRefPubMedPubMedCentral Wallner LP, et al. Ten-year trends in preventive service use before and after prostate cancer diagnosis: a comparison with noncancer controls. Perm J. 2017;21:16–184.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.CrossRefPubMed Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.CrossRefPubMed
19.
Zurück zum Zitat Finley CR, et al. What are the most common conditions in primary care? Systematic review. 2018;64(11):832–40. Finley CR, et al. What are the most common conditions in primary care? Systematic review. 2018;64(11):832–40.
21.
Zurück zum Zitat Akinyemiju T, et al. Disparities in the prevalence of comorbidities among US adults by state Medicaid expansion status. Prev Med. 2016;88:196–202.CrossRefPubMedPubMedCentral Akinyemiju T, et al. Disparities in the prevalence of comorbidities among US adults by state Medicaid expansion status. Prev Med. 2016;88:196–202.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
24.
Zurück zum Zitat Pruitt SL, et al. Cervical cancer burden and opportunities for prevention in a safety-net healthcare system. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1398–406. Pruitt SL, et al. Cervical cancer burden and opportunities for prevention in a safety-net healthcare system. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1398–406.
26.
Zurück zum Zitat Craddock Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRef Craddock Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRef
27.
Zurück zum Zitat Balasubramanian BA et al. Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord. 2018;21(1-2):26–35. Balasubramanian BA et al. Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord. 2018;21(1-2):26–35.
28.
Zurück zum Zitat Balsubramanian BA et al. Thematic analyses of challenges of care coordination for underinsured and uninsured cancer survivors with chronic conditions. JAMA Netw Open. 2021;4(8):e2119080. Balsubramanian BA et al. Thematic analyses of challenges of care coordination for underinsured and uninsured cancer survivors with chronic conditions. JAMA Netw Open. 2021;4(8):e2119080.
29.
Zurück zum Zitat George A, Rubin G. Non-attendance in general practice: a systematic review and its implications for access to primary health care. Fam Pract. 2003;20(2):178–84.CrossRefPubMed George A, Rubin G. Non-attendance in general practice: a systematic review and its implications for access to primary health care. Fam Pract. 2003;20(2):178–84.CrossRefPubMed
30.
Zurück zum Zitat Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J Prim Care Community Health. 2013;4(4):251–5.CrossRefPubMed Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J Prim Care Community Health. 2013;4(4):251–5.CrossRefPubMed
31.
Zurück zum Zitat Shimotsu S, et al. Increased likelihood of missed appointments (“no shows”) for racial/ethnic minorities in a safety net health system. J Prim Care Community Health. 2016;7(1):38–40.CrossRefPubMed Shimotsu S, et al. Increased likelihood of missed appointments (“no shows”) for racial/ethnic minorities in a safety net health system. J Prim Care Community Health. 2016;7(1):38–40.CrossRefPubMed
32.
33.
Zurück zum Zitat Nekhlyudov L, O’Malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral Nekhlyudov L, O’Malley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017;18(1):e30–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Doose M, et al. Comorbidity management in black women diagnosed with breast cancer: the role of primary care in shared care. J Gen Intern Med. 2021;36(1):138–46.CrossRefPubMed Doose M, et al. Comorbidity management in black women diagnosed with breast cancer: the role of primary care in shared care. J Gen Intern Med. 2021;36(1):138–46.CrossRefPubMed
36.
37.
Zurück zum Zitat Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRefPubMedPubMedCentral Lee SJ, et al. Achieving coordinated care for patients with complex cases of cancer: a multiteam system approach. J Oncol Pract. 2016;12(11):1029–38.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Lee SJC, et al. Care coordination for complex cancer survivors in an integrated safety-net system: a study protocol. BMC Cancer. 2018;18(1):1204.CrossRefPubMedPubMedCentral Lee SJC, et al. Care coordination for complex cancer survivors in an integrated safety-net system: a study protocol. BMC Cancer. 2018;18(1):1204.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Lemieux-Charles L, McGuire WL. What do we know about health care team effectiveness? A review of the literature. Med Care Res Rev. 2006;63(3):263–300.CrossRefPubMed Lemieux-Charles L, McGuire WL. What do we know about health care team effectiveness? A review of the literature. Med Care Res Rev. 2006;63(3):263–300.CrossRefPubMed
42.
43.
Zurück zum Zitat O’Malley D, et al. Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. J Cancer Surviv. 2017;11(1):13–23.CrossRefPubMed O’Malley D, et al. Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. J Cancer Surviv. 2017;11(1):13–23.CrossRefPubMed
44.
Zurück zum Zitat Parsons SK, et al. Promoting high-quality cancer care and equity through disciplinary diversity in team composition. J Oncol Pract. 2016;12(11):1141–7.CrossRefPubMed Parsons SK, et al. Promoting high-quality cancer care and equity through disciplinary diversity in team composition. J Oncol Pract. 2016;12(11):1141–7.CrossRefPubMed
Metadaten
Titel
Importance of primary care for underserved cancer patients with multiple chronic conditions
verfasst von
Katelyn K. Jetelina
Simon Craddock Lee
Quiera S. Booker-Nubie
Udoka C. Obinwa
Hong Zhu
Michael E. Miller
Navid Sadeghi
Umber Dickerson
Bijal A. Balasubramanian
Publikationsdatum
05.01.2022
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 5/2023
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01159-8

Weitere Artikel der Ausgabe 5/2023

Journal of Cancer Survivorship 5/2023 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.